The metabolic effects of R-phenylisopropyl adenosine (R-PIA), an agonist of adenosine Al receptors, were studied by in vivo 31p NMR spectroscopy before, during, and after 30 min of reversible forebrain ischemia in the rat. R-PIA had no effect on cerebral metabolism before ischemia. During a 30-min ischemia, R-PIA re duced the decrease in phosphocreatine (43 ± 11% of the control level at the end of ischemia vs. 27 ± 9% in the reference group) and ATP (58 ± 12% vs. 40 ± 23%) and the increase in inorganic phosphate (672 ± 210% vs. 905
Cerebral pathologies such as hypoxia (Winn et aI., 1981) , hypotension (Winn et aI., 1980) , ischemia (Winn et aI., 1979a) , or seizures (Winn et aI., 1979b) lead to a rapid, large increase in extracellular aden osine. Adenosine can hyperpolarize neurons, in hibit the release of excitatory amino acids and ace tylcholine (Corradetti et aI., 1984; Fredholm and Dunwiddie, 1988) , inhibit calcium uptake (directly and/or via an activation of a potassium conduc tance) and sodium fluxes, and produce vasodilation (Dragunow and Faull, 1988) . Adenosine also inhib its platelets and neutrophil aggregation (Cronstein et aI., 1986) . In addition, adenosine has been pro posed as an endogenous neuroprotector (Phillis, 1989) . It therefore seems very likely that an in-crease in central adenosine tone can alter the extent of cerebral ischemic damage, thus providing a po tentially new approach for the treatment of stroke.
We have therefore investigated the possible ther apeutic effects of adenosine agonists on the neuro nal consequences of ischemia. Adenosine agonists limit the neuronal loss following ischemia (Block and Pulsinelli, 1987; Evans et aI., 1987; von Lubitz et aI., 1988; Bielenberg, 1989) while antagonists ex acerbate the consequences of ischemia (Rudolphi et aI., 1987) . Adenosine agonists can also reduce the downregulation of the Al receptors elicited by isch emia (Daval et aI., 1989) . However, the precise manner in which adenosine acts remains hypothet ical (Dragunow and Faull, 1988) .
One of the more potent agonist of the adenosine Al receptors is R-phenylisopropyladenosine (R PIA) (Daly, 1982) . This drug inhibits glutamate re lease from hippocampal slices (Fastbom and Fred holm, 1985) . This is particularly relevant as adeno sine Al receptors and N-methyl-D-aspartate (NMDA) binding sites have similar distributions (with some exceptions) in the brain (Goodman and Snyder, 1982; Young and Fagg, 1990) . R-PIA also reduces the neurotoxicity of the excitatory amino acid receptor agonist quinolinic acid (Connick and Stone, 1989) . It has been used to protect against neuronal damage in both global ischemia (Block and Pulsinelli, 1987) and focal ischemia (Bielenberg, 1989) . The protective effects were assessed from the results of postmortem histological studies. However, it is still unclear which of the numerous properties of adenosine and adenosine agonists are involved; the metabolic effects of R-PIA treatment are unknown.
We have used phosphorus-31 nuclear magnetic resonance e1p NMR) spectroscopy, which is a suit able noninvasive technique for characterizing the changes in the cerebral bioenergetic state in vivo (Gyulai et al., 1987; Sauter and Rudin, 1987; Roucher et aI., 1989a,b) , to monitor the cerebral metabolic effects of R-PIA before, during, and after reversible forebrain ischemia in the rat.
MATERIALS AND METHODS
Male Wistar rats (Charles River, Cleon, France) (280-330 g) were made ischemic according to the "four-vessel occlusion" model of Pulsinelli and Brierley (1979) . The day before the experiment, rats were anesthetized with 1% halothane in 70% Nz/30% O2 and the two vertebral arteries were exposed at the level of the first cervical vertebra with a dental drill. They were electrocoagulated by bipolar diathermy under direct vision (Todd et aI., 1986) . The day of the experiment, rats were anesthetized with 1% halothane in 70% Nz/30% 02' The scalp was removed and the temporal muscles were retracted to min imize any muscle contribution to the NMR signal. Three subdural silver electrodes were sealed with methyl methacrylate dental cement in the bone of the skull for electrocorticogram (ECoG) recording. The right femoral artery was cannulated for blood pressure monitoring and sampling for blood gas analysis. Body temperature was kept close to 37°C using a heating pad and a rectal tem perature probe. The two common carotid arteries were carefully isolated and snared with atraumatic devices via a ventral neck incision. The rats were then tracheoto mized, paralyzed (1.5 mg/kg of d-tubocurarine i.v.), and given 30 mg/kg of a-chloralose; halothane was discontin ued. The tidal volume and respiratory rate were adjusted to maintain normocapnia and normoxia. A homemade nonmagnetic stereotaxic holder was used to place a dou ble-turn rectangular surface coil (8 x 12 mm) on the skull. The holder contained temperature-regulated water circu lation to maintain core temperature at 3rC throughout the experiment. The whole device was positioned in the bore of the horizontal magnet (4.7 T, <I> = 30 cm) of the spectrometer (MEDSPEC, Bruker BMT 47/30, Karl sruhe, Germany). After shimming (0.1 to 0.2 ppm), 31p NMR spectra were obtained at 81 MHz from 96 scans over 300 s. A low energy, long duration pre saturation pulse (90 mW, 100 ms) was used to remove the broad resonance due to the low mobility phosphates of bone and phospholipids (Gonzalez-Mendez et aI., 1984) . Chemical shifts were measured relative to the phosphocreatine J Cereb Blood Flow Metab, Vol. 11, No.3, 1991 peak position, which was taken as zero. The intracellular pH (pHi) was calculated from the following relationship (De corps et al., 1984) :
where BPi is the chemical shift of the inorganic phosphate peak. Changes in the relative concentrations of the phos phorus compounds identified on the spectra were esti mated from their peak areas, expressed as a percent of the area of the peaks in the control spectra.
The cerebral metabolism of two groups of randomly chosen rats was monitored for 3 h by 31p NMR spectros copy. The reference group (n = 20) received no drug treatment and underwent a 30 min reversible ischemia by clamping both carotid arteries 45 min after the beginning of NMR monitoring. Monitoring was continued during the recovery for up to 90 min after the end of the isch emia. The treated group (n = 17) underwent the same protocol but was given 20 fLg/kg of R-PIA i.p. 30 min before ischemia, followed by 10 fLg/kg of R-PIA every hour. This dose of R-PIA was selected after pilot exper iments showed it had significant cardiovascular effects (decrease in arterial pressure = 10-15 mm Hg), indicating an efficient stimulation of the systemic adenosinergic re ceptors, which remained far below the threshold of cere bral blood perfusion autoregulation. R-PIA was obtained from Sigma Chemical Co. (St. Louis, MO, U.S.A.).
As previously observed by others (Schmidt-Kastner et aI., 1989), several animals exhibited persistent brain elec trical activity after carotid clamping, indicating a residual blood flow above the flow threshold required for any per turbation of energy metabolism. These animals, which showed no changes in the NMR spectra, were considered nonischemic and were excluded from further studies (five animals in the reference group and four animals in the treated group). It has also previously been observed in this model of ischemia (Todd et aI., 1986 ) that some of the animals do not recover their blood supply after ischemia ("no reflow" phenomenon), but remain ischemic and so have an isoelectric ECoG. Those rats that had a com pletely flat ECoG at the end of the 90 min recirculation period were not included in the two groups presented (three rats in the reference group and three rats in the treated group).
These experiments were authorized by permit no. 727 from the French Ministere de l'Industrie et de la Re cherche.
The data obtained on the relative levels of energy me tabolites and intracellular pH were analyzed by one-way analysis of variance to compare the two groups in the preischemic state. Differences between the two groups were estimated by an unpaired "t" test (Zar, 1984) .
RESULTS
The in vivo 31p NMR spectrum of the rat brain exhibited seven peaks (Fig. 1 ). They were identified as the resonances from phosphomonoesters (PMEs), inorganic phosphate (Pi), phosphodiesters (PDEs), phosphocreatine (PCr), and the three phos phates (,,(, a, �) of nucleotide triphosphates. In the brain, nucleotide triphosphates are mainly com posed of ATP so we have used, as in most of the NMR studies, the general term of A TP. The "I and a peaks are known to contain resonances from NAD and ADP (Glonek et aI., 1982) ; only the 13 peak is due exclusively to ATP. In the reference group (Fig. 2) , Pi increased dur ing the ischemia to reach 905 ± 229% (mean ± SD) of the control level. During the same period, PCr and ATP decreased to 27 ± 9 and 40 ± 23% of the control level at the end of the ischemia, respec tively. Ischemia also induced a fall in pHi (to 6.30 ± 0.10 from 7.13 ± 0.05). The ECoG showed an elec trical silence within the first 30 s after the onset of the ischemia. Recirculation was associated with a complete recovery of PCr and ATP to control val ues in 20 min and a slower recovery of Pi and pHi (45 min). Cerebral electrical activity reappeared af ter 30 min of recovery and was near normal after 90 min.
In the treated group (Fig. 2) , the control state was not significantly different from that of the reference group for the NMR parameters and physiological variables. R-PIA injection induced no significant changes in the 31 P spectra or in the data provided by the physiological monitoring, except for a moderate decrease in the mean arterial pressure (10-15 mm Hg) (Table O . In this group, Pi increased during the ischemia but reached a lower level (672 ± 210%) than in the reference group. Similarly, ischemia in duced a fall in PCr and A TP but the levels reached at the end of the ischemia were lower (43 ± 11 and 58 ± 12% of the control group, respectively) than in the reference group. The decrease in pHi (6.40 ± 0.10) was statistically different from that of the ref erence group only during the last part of ischemia. The Pi and pHi returned to control levels during recirculation three times faster than in the reference group and PCr and ATP recovery was also a little faster.
DISCUSSION
Our results have shown that R-PIA did not mod ify energy homeostasis under control conditions, but did attenuate the energy failure elicited by a 30 MABP 115 ± 7 103 ± 5 120 ± 17 12 1 ± 12 pC02, p02' and mean arterial blood pressure (MABP) are ex pressed in mm Hg. No statistically significant differences were seen between groups for any variables except MABP before the ischemia (p < 0.05). min forebrain ischemia. Recovery to control values after ischemia was also accelerated by R-PIA treat ment.
Several problems limit investigations of the cere bral content of the high energy compounds impli cated in the energy metabolism by classical bio chemical methods. These methods are invasive and so cannot monitor the time course of changes in energy compounds in the same animal. There is also a good chance that the data will be inaccurate as there is a rapid postmortem decay in the very labile high energy phosphates. However, the problems encountered with the classical biochemical methods have been elegantly eliminated by the application of high resolution NMR spectroscopy to in vivo ex periments (Ackerman et aI., 1980) . In vivo 31p NMR spectroscopy provides noninvasive measurements of high energy phosphate content that can be re peated on the same subject. This method can also evaluate the intracellular pH, which is of great im portance in the pathophysiology of ischemia, There are several experimental models for pro-ducing reversible complete or incomplete global ischemia (Karpiak et aI., 1989) . One of most widely used is the "four-vessel occlusion" model of Pulsinelli and Brierley (1979) ; it is easy to set up and induces no systemic hypoxia, hypotension, or gen eralized seizures. It has been shown (Pulsinelli and Brierley, 1979 ) that this kind of ischemia does not affect either the rachidian bulb or the cerebellum, which are irrigated by the anterior spinal artery, whereas the parietal cortex, striatum, and hippo campus are profoundly affected. Cerebral blood flow is very reduced but not completely stopped during ischemia (Furlow, 1982; Todd et aI., 1986) , so that it may be considered as a model of global incomplete ischemia. We found that ischemia induced a marked de crease in ATP and PCr, but not their complete elim ination. This could be due to the residual blood flow described above and to a small contribution to the NMR signal from the head muscles. The muscle contribution was estimated to be between 5 and 10% of the whole NMR signal by comparing the PCrl ATP ratio computed from "fully relaxed spectra" (PCrl ATP = 1.9), with the PCrl A TP ratios of 1. 8 for the rat brain (Sauter and Rudin, 1987) and 4.04 for muscle (Ackerman et aI., 1980) . This range of extracerebral contribution to the NMR signal was confirmed by the time course of the postmor tem decrease in PCr and A TP. PCr and A TP com pletely disappeared from the brain in 4 min, but persisted for over 2 h in extracerebral tissue (Petroff et aI., 1985) . The residual levels of PCr and ATP measured by NMR just after death were very low. Thus, the levels of PCr and ATP measured at the end of a 30 min four-vessel occlusion were clearly too high to be attributed only to the extracerebral contribution. Moreover, the reproducibility of the metabolic effects of this kind of ischemia is high enough for a pharmacological investigation of the time course of the possible metabolic consequences of drug treatment before, during, and after isch emia.
The modifications induced by R-PIA during isch emia show that the amount of R-PIA that reached the brain was sufficient to interfere with cerebral metabolism, as previously shown (N ehlig et aI., 1988) . However, R-PIA per se did not modify the energy equilibrium.
The present results show that R-PIA preserves the cerebral PCr and ATP contents during ischemia and accelerates the recovery of PCr, Pi, ATP, and intracellular brain pH during postischemic reperfu sion. These results suggest that adenosine agonists protect cerebral energy metabolism during isch emia. This protection may be due to any one of the numerous effects of adenosine on the central ner-vous system. Nevertheless, it is unlikely that a vas cular effect is responsible for these metabolic ef fects since R-PIA is one of the most selective Al agonists (Daly, 1982) ; cerebral vessels have A 2 but not Al receptors (Kalaria and Harik, 1988) , and it has been shown that these doses of R-PIA have no cerebrovascular effects (Nehlig et aI., 1990) .
It seems also that the inhibition of the release of excitatory amino acids (EAAs) by R-PIA via a stim ulation of the Al adenosine receptors, as previously suggested (Block and Pulsinelli, 1987) , is not in volved in the metabolic effects of this drug since it has been shown that EAA receptor antagonists fail to limit the decrease in A TP during ischemia (Roucher et aI., 1989a) .
Moreover, the hyperpolarization of neurons elic ited by adenosine (Dragunow and Faull, 1988) would lead to inhibition of the NMDA receptors via voltage-dependent blockade by Mg 2 + of the ionic channel coupled to these receptors. This effect of adenosine could be also excluded since we have shown that there is a very small difference in the time course of the intracellular pH and the level of acidosis reached at the end of ischemia in the two groups of animals. Our results show that R-PIA does not protect the cerebral cells from the gross perturbations of the ionic equilibrium induced by ischemia and then from the resulting depolarization.
It seems that the limited decrease in the cerebral content of PCr and ATP indicates that R-PIA may protect neurons by reducing cerebral energy con sumption. This hypothesis is corroborated by other studies that have shown a reduction in the local cerebral metabolic rate of glucose consumption by R-PIA (Nehlig et aI., 1988) and by another adeno sine agonist, cyclohexyl adenosine (Grome and Ste fanovitch, 1986).
The accelerated recovery of PCr, Pi, ATP, and pHi to control values could be due to the protection of the energy production functions during ischemia as described above. These functions are then more efficient during the early phase of the postischemic period. There may also be better oxygenation of the cerebral tissue due to better microcirculation linked to the antiaggregant properties of adenosine (Sku bitz et aI., 1988) .
It is also possible that the drug interferes with the metabolic transformation of adenosine to inosine and hypoxanthine (Kleihues et aI., 1974) . If it did, the action could favor better recovery by reducing the need to resynthesize adenosine or by reducing any deleterious effects of inosine and hypoxan thine.
These results indicate that the protective proper ties of adenosine agonists against ischemic injury are due to a reduction in energy failure elicited by ischemia, and to an accelerated recovery of normal energy production. In view of this, adenosine ago nists could provide a practical therapeutic approach to cerebral ischemia.
